Charles Brandes acquired 7.05 Million Pfizer shares worth $175 Million. That's 1.78% of their equity portfolio (17th largest holding). The first Pfizer trade was made in Q1 2013. Since then Charles Brandes bought shares twenty more times and sold shares on 28 occasions. The investor's estimated purchase price is $210 Million, resulting in a loss of 17%.